A detailed history of Gabelli Funds LLC transactions in Zoetis Inc. stock. As of the latest transaction made, Gabelli Funds LLC holds 87,203 shares of ZTS stock, worth $14.4 Million. This represents 0.13% of its overall portfolio holdings.

Number of Shares
87,203
Previous 82,878 5.22%
Holding current value
$14.4 Million
Previous $14.4 Million 18.58%
% of portfolio
0.13%
Previous 0.12%

Shares

29 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 13, 2024

BUY
$172.58 - $196.48 $746,408 - $849,776
4,325 Added 5.22%
87,203 $17 Million
Q2 2024

Aug 13, 2024

SELL
$145.54 - $178.83 $20.5 Million - $25.2 Million
-140,739 Reduced 62.94%
82,878 $14.4 Million
Q1 2024

May 14, 2024

SELL
$165.67 - $199.94 $987,558 - $1.19 Million
-5,961 Reduced 2.6%
223,617 $37.8 Million
Q4 2023

Feb 13, 2024

SELL
$151.44 - $200.09 $4.57 Million - $6.04 Million
-30,165 Reduced 11.61%
229,578 $45.3 Million
Q3 2023

Nov 08, 2023

SELL
$167.14 - $192.77 $447,935 - $516,623
-2,680 Reduced 1.02%
259,743 $45.2 Million
Q2 2023

Aug 10, 2023

BUY
$160.94 - $186.23 $7.29 Million - $8.43 Million
45,270 Added 20.85%
262,423 $45.2 Million
Q1 2023

May 12, 2023

BUY
$145.48 - $175.02 $928,889 - $1.12 Million
6,385 Added 3.03%
217,153 $36.1 Million
Q4 2022

Feb 13, 2023

SELL
$131.14 - $157.47 $5.09 Million - $6.11 Million
-38,800 Reduced 15.55%
210,768 $30.9 Million
Q3 2022

Nov 10, 2022

SELL
$148.29 - $182.55 $48,194 - $59,328
-325 Reduced 0.13%
249,568 $37 Million
Q2 2022

Aug 12, 2022

SELL
$155.97 - $200.09 $920,223 - $1.18 Million
-5,900 Reduced 2.31%
249,893 $43 Million
Q1 2022

May 13, 2022

SELL
$181.39 - $234.03 $2.35 Million - $3.03 Million
-12,965 Reduced 4.82%
255,793 $48.2 Million
Q4 2021

Feb 11, 2022

BUY
$193.69 - $247.03 $2.87 Million - $3.66 Million
14,820 Added 5.84%
268,758 $65.6 Million
Q3 2021

Nov 12, 2021

SELL
$189.29 - $209.69 $1.52 Million - $1.69 Million
-8,050 Reduced 3.07%
253,938 $49.3 Million
Q2 2021

Aug 13, 2021

SELL
$155.9 - $187.99 $834,065 - $1.01 Million
-5,350 Reduced 2.0%
261,988 $48.8 Million
Q1 2021

May 14, 2021

SELL
$144.0 - $169.39 $7.02 Million - $8.26 Million
-48,760 Reduced 15.43%
267,338 $42.1 Million
Q4 2020

Feb 05, 2021

BUY
$157.07 - $174.35 $48,691 - $54,048
310 Added 0.1%
316,098 $52.3 Million
Q3 2020

Nov 06, 2020

SELL
$137.1 - $165.37 $1.06 Million - $1.28 Million
-7,750 Reduced 2.4%
315,788 $52.2 Million
Q2 2020

Aug 13, 2020

SELL
$111.92 - $142.53 $14.4 Million - $18.3 Million
-128,650 Reduced 28.45%
323,538 $44.3 Million
Q1 2020

May 14, 2020

SELL
$92.66 - $144.94 $2.28 Million - $3.57 Million
-24,600 Reduced 5.16%
452,188 $53.2 Million
Q4 2019

Feb 14, 2020

SELL
$116.25 - $133.25 $3.47 Million - $3.98 Million
-29,864 Reduced 5.89%
476,788 $63.1 Million
Q3 2019

Nov 01, 2019

SELL
$112.57 - $128.43 $1.24 Million - $1.41 Million
-11,000 Reduced 2.12%
506,652 $63.1 Million
Q2 2019

Aug 02, 2019

SELL
$97.98 - $114.28 $1.49 Million - $1.74 Million
-15,250 Reduced 2.86%
517,652 $58.7 Million
Q1 2019

May 02, 2019

SELL
$81.56 - $100.67 $4.15 Million - $5.12 Million
-50,900 Reduced 8.72%
532,902 $53.6 Million
Q4 2018

Jan 30, 2019

SELL
$79.28 - $95.27 $1.98 Million - $2.38 Million
-25,000 Reduced 4.11%
583,802 $49.9 Million
Q3 2018

Nov 02, 2018

SELL
$83.5 - $93.23 $279,725 - $312,320
-3,350 Reduced 0.55%
608,802 $55.7 Million
Q2 2018

Aug 10, 2018

SELL
$79.9 - $89.2 $291,635 - $325,580
-3,650 Reduced 0.59%
612,152 $52.1 Million
Q1 2018

May 09, 2018

SELL
$71.51 - $84.69 $3.9 Million - $4.62 Million
-54,500 Reduced 8.13%
615,802 $51.4 Million
Q4 2017

Feb 02, 2018

SELL
$63.24 - $72.8 $6.97 Million - $8.02 Million
-110,152 Reduced 14.11%
670,302 $48.3 Million
Q3 2017

Nov 01, 2017

BUY
$59.73 - $65.4 $46.6 Million - $51 Million
780,454
780,454 $49.8 Million

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $77.1B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Gabelli Funds LLC Portfolio

Follow Gabelli Funds LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Gabelli Funds LLC, based on Form 13F filings with the SEC.

News

Stay updated on Gabelli Funds LLC with notifications on news.